Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 30, 1996 - Issue 4
Submit an article Journal homepage
29
Views
9
CrossRef citations to date
0
Altmetric
Original Paper

The Effect of Buserelin Versus Conventional Antiandrogenic Treatment in Patients with T2-4NXM1 Prostatic Cancer

A Prospective, Randomized Multicentre Phase III Trial

E. Bruun Department of Urology, Gentofte Hospital, University of Copenhagen, Denmark
,
C. Frimodt-Møller Department of Urology, Gentofte Hospital, University of Copenhagen, Denmark
& Danish Buserelin Study Group
Pages 291-297 | Received 29 Jan 1993, Accepted 03 Aug 1995, Published online: 15 Feb 2010

REFERENCES

  • Brogden RN, Buckley MM-T, Ward A. Buserelin; A review of its Pharmacodynamic and Pharmacokinetic Properties, and Clinical Profile. Drugs 1990; 39: 339–437.
  • Chodak GW, Vogelzang NJ, Caplan RJ, Soloway M, Smith JA. Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. JAMA 1991; 265: 618–621.
  • Citrin DL, Resnick MI, Guinan P, et al. A comparison of Zoladex and DES in the treatment of advanced prostate cancer: Results of a randomized, multicenter trial. Prostate 1991; 18: 139–146.
  • Crawford ED. Hormonal therapy of prostatic carcinoma. Cancer 1990; 66: 1035–1038.
  • DeVoogt HJ, Klijn JGM, Studer U, Schröder F, Sylvester R,DePauw and members of the EORTC-GU Group. Orchidectomy versus Buserelin in combination with cyproterone acetate, for 2 weeks or continuously, in the treatment of metastatic prostatic cancer. Preliminary results of EORTC-Trial 30843. J Steroid Bio-chem Mol Biol 1990; 37: 965–969.
  • DeVoogt HJ, Adenauer H, Widra WG. The use of the LHRH-analogue Buserelin in the treatment of prostatic cancer. Scand J Urol Nephrol 1991; (Suppl 138): 131–136.
  • Ernst DS, Hanson J, Venner PM. Uro-oncology Group of Northern Alberta. Analysis of prognostic factors in men with metastatic prostate cancer. J Urol 1991; 146: 372–376.
  • Huben RP, Murphy GP, and The investigators of the national prostatic cancer project. A comparison of diethylstilbestrol or orchiectomy with Buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate. Cancer 1988; 62: 1881–1887.
  • Huhtaniemi I, Venho P, Jacobi G, Ranniko S. Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer. J Androl 1991; 12: 46–53.
  • Ishikawa S, Soloway MS, Zwaag R, Todd B. Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancer. J Urol 1989; 141: 1139–1142.
  • Klioze SS, Miller MF, Spiro TP, and The NPCP Protocol 1700B Study Group. A randomized comparative study of Buserelin with DES/orchiectomy in the treatment of stage D2 prostatic cancer patients. Am J Clin Oncol (CCT) 1988; 11: S176–S182.
  • Parmar H, Philips RH, Lightman SL, Edwards L. How would you like to have an orchidectomy for advanced prostatic cancer? Am J Clin Oncol (CCT) 1988; 11: S160–S168.
  • Schröder F. Hormonal manipulation of prostatic cancer. Too soon for total androgen blockade? BMJ 1991; 303: 1489–1490.
  • Soloway MS. The importance of prognostic factors in advanced prostate cancer. Cancer 1990; 66: 1017–1021.
  • Thompson IM, Zeidman EJ, Rodriguez FR. Sudden death due to disease flare with luteinizing hormone-releasing hormone agonist therapy for carcinoma of the prostate. J Urol 1990; 144: 1479–1480.
  • Wulff HR, Schlicting P. Medstat. A statistic program for analysis of results of clinical trials. Copenhagen 1987.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.